Patungan, Nahda M.
HRN: 21-13-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2023
CEFUROXIME 750MG (VIAL)
12/12/2023
12/18/2023
IV
750mg
Q8hr
Incomplete Abortion
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes